Our results confirm that targeting the ISS-N1 region leads to efficient modulation of the SMN2 transcript and indicate that optimization of the target sequence, even with small variations in the MO sequence, can achieve more efficient production of functional SMN protein, consequently ameliorating the SMA disease phenotype. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.